vs
Astrana Health, Inc.（ASTH）与Dynatrace, Inc.（DT）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Dynatrace, Inc.的1.8倍（$950.5M vs $515.5M），Dynatrace, Inc.净利率更高（7.8% vs 0.7%，领先7.1%），Astrana Health, Inc.同比增速更快（42.9% vs 18.2%），Dynatrace, Inc.自由现金流更多（$27.2M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 16.3%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Dynatrace是总部位于美国的跨国科技企业，主打AI驱动的可观测性平台，旗下软件可用于应用性能监控分析、软件开发流程优化、网络安全防护、IT基础设施运维及用户体验提升等场景，为各行业客户的数字化运营提供有力技术支撑。
ASTH vs DT — 直观对比
营收规模更大
ASTH
是对方的1.8倍
$515.5M
营收增速更快
ASTH
高出24.7%
18.2%
净利率更高
DT
高出7.1%
0.7%
自由现金流更多
DT
多$33.2M
$-6.0M
两年增速更快
ASTH
近两年复合增速
16.3%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $515.5M |
| 净利润 | $6.6M | $40.1M |
| 毛利率 | — | 81.4% |
| 营业利润率 | 1.9% | 14.1% |
| 净利率 | 0.7% | 7.8% |
| 营收同比 | 42.9% | 18.2% |
| 净利润同比 | 184.4% | -88.9% |
| 每股收益（稀释后） | $0.12 | $0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHDT
| Q4 25 | $950.5M | $515.5M | ||
| Q3 25 | $956.0M | $493.8M | ||
| Q2 25 | $654.8M | $477.3M | ||
| Q1 25 | $620.4M | $445.2M | ||
| Q4 24 | $665.2M | $436.2M | ||
| Q3 24 | $478.7M | $418.1M | ||
| Q2 24 | $486.3M | $399.2M | ||
| Q1 24 | $404.4M | $380.8M |
净利润ASTHDT
| Q4 25 | $6.6M | $40.1M | ||
| Q3 25 | $373.0K | $57.2M | ||
| Q2 25 | $9.4M | $48.0M | ||
| Q1 25 | $6.7M | $39.3M | ||
| Q4 24 | $-7.8M | $361.8M | ||
| Q3 24 | $16.1M | $44.0M | ||
| Q2 24 | $19.2M | $38.6M | ||
| Q1 24 | $14.8M | $37.9M |
毛利率ASTHDT
| Q4 25 | — | 81.4% | ||
| Q3 25 | — | 81.8% | ||
| Q2 25 | — | 82.1% | ||
| Q1 25 | — | 80.9% | ||
| Q4 24 | — | 81.1% | ||
| Q3 24 | — | 81.4% | ||
| Q2 24 | — | 81.3% | ||
| Q1 24 | — | 81.1% |
营业利润率ASTHDT
| Q4 25 | 1.9% | 14.1% | ||
| Q3 25 | 2.0% | 14.8% | ||
| Q2 25 | 3.1% | 13.1% | ||
| Q1 25 | 3.3% | 9.6% | ||
| Q4 24 | 0.1% | 10.9% | ||
| Q3 24 | 5.9% | 11.2% | ||
| Q2 24 | 6.2% | 10.5% | ||
| Q1 24 | 7.5% | 6.1% |
净利率ASTHDT
| Q4 25 | 0.7% | 7.8% | ||
| Q3 25 | 0.0% | 11.6% | ||
| Q2 25 | 1.4% | 10.0% | ||
| Q1 25 | 1.1% | 8.8% | ||
| Q4 24 | -1.2% | 82.9% | ||
| Q3 24 | 3.4% | 10.5% | ||
| Q2 24 | 3.9% | 9.7% | ||
| Q1 24 | 3.7% | 10.0% |
每股收益（稀释后）ASTHDT
| Q4 25 | $0.12 | $0.13 | ||
| Q3 25 | $0.01 | $0.19 | ||
| Q2 25 | $0.19 | $0.16 | ||
| Q1 25 | $0.14 | $0.12 | ||
| Q4 24 | $-0.14 | $1.19 | ||
| Q3 24 | $0.33 | $0.15 | ||
| Q2 24 | $0.40 | $0.13 | ||
| Q1 24 | $0.31 | $0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $1.2B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $2.7B |
| 总资产 | $2.2B | $4.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHDT
| Q4 25 | $429.5M | $1.2B | ||
| Q3 25 | $463.4M | $1.3B | ||
| Q2 25 | $342.1M | $1.3B | ||
| Q1 25 | $260.9M | $1.1B | ||
| Q4 24 | $290.8M | $1.0B | ||
| Q3 24 | $350.3M | $1.0B | ||
| Q2 24 | $327.7M | $1.0B | ||
| Q1 24 | $337.3M | $836.9M |
股东权益ASTHDT
| Q4 25 | $779.3M | $2.7B | ||
| Q3 25 | $775.5M | $2.8B | ||
| Q2 25 | $765.5M | $2.7B | ||
| Q1 25 | $745.4M | $2.6B | ||
| Q4 24 | $712.7M | $2.6B | ||
| Q3 24 | $704.6M | $2.1B | ||
| Q2 24 | $678.9M | $2.1B | ||
| Q1 24 | $653.5M | $2.0B |
总资产ASTHDT
| Q4 25 | $2.2B | $4.1B | ||
| Q3 25 | $2.2B | $4.1B | ||
| Q2 25 | $1.4B | $4.1B | ||
| Q1 25 | $1.3B | $4.1B | ||
| Q4 24 | $1.4B | $3.7B | ||
| Q3 24 | $1.3B | $3.3B | ||
| Q2 24 | $1.3B | $3.3B | ||
| Q1 24 | $1.2B | $3.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $33.8M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $27.2M |
| 自由现金流率自由现金流/营收 | -0.6% | 5.3% |
| 资本支出强度资本支出/营收 | 0.3% | 1.3% |
| 现金转化率经营现金流/净利润 | -0.44× | 0.84× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $465.5M |
8季度趋势，按日历期对齐
经营现金流ASTHDT
| Q4 25 | $-2.9M | $33.8M | ||
| Q3 25 | $10.0M | $32.0M | ||
| Q2 25 | $90.9M | $269.7M | ||
| Q1 25 | $16.6M | $162.8M | ||
| Q4 24 | $-10.9M | $42.2M | ||
| Q3 24 | $34.0M | $23.6M | ||
| Q2 24 | $23.2M | $230.7M | ||
| Q1 24 | $6.0M | $131.7M |
自由现金流ASTHDT
| Q4 25 | $-6.0M | $27.2M | ||
| Q3 25 | $7.4M | $27.8M | ||
| Q2 25 | $89.5M | $262.2M | ||
| Q1 25 | $13.6M | $148.2M | ||
| Q4 24 | $-13.5M | $37.6M | ||
| Q3 24 | $31.7M | $20.1M | ||
| Q2 24 | $20.4M | $227.4M | ||
| Q1 24 | $5.6M | $121.9M |
自由现金流率ASTHDT
| Q4 25 | -0.6% | 5.3% | ||
| Q3 25 | 0.8% | 5.6% | ||
| Q2 25 | 13.7% | 54.9% | ||
| Q1 25 | 2.2% | 33.3% | ||
| Q4 24 | -2.0% | 8.6% | ||
| Q3 24 | 6.6% | 4.8% | ||
| Q2 24 | 4.2% | 57.0% | ||
| Q1 24 | 1.4% | 32.0% |
资本支出强度ASTHDT
| Q4 25 | 0.3% | 1.3% | ||
| Q3 25 | 0.3% | 0.8% | ||
| Q2 25 | 0.2% | 1.6% | ||
| Q1 25 | 0.5% | 3.3% | ||
| Q4 24 | 0.4% | 1.1% | ||
| Q3 24 | 0.5% | 0.8% | ||
| Q2 24 | 0.6% | 0.8% | ||
| Q1 24 | 0.1% | 2.6% |
现金转化率ASTHDT
| Q4 25 | -0.44× | 0.84× | ||
| Q3 25 | 26.69× | 0.56× | ||
| Q2 25 | 9.65× | 5.62× | ||
| Q1 25 | 2.48× | 4.14× | ||
| Q4 24 | — | 0.12× | ||
| Q3 24 | 2.11× | 0.54× | ||
| Q2 24 | 1.21× | 5.97× | ||
| Q1 24 | 0.40× | 3.47× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
DT
| Subscription And Circulation | $493.4M | 96% |
| Services | $22.1M | 4% |
